Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WHIP COVID-19: Hydroxychloroquine for COVID-19 Prevention
NCT04341441Phase 3Terminated
- Sponsor
- Henry Ford Health
- Start
- Apr 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Henry Ford Health. Started Apr 2020; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04341441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341441.